Meta Unveils Subscription Plans to Offset Rising AI Expenditure Diversify Revenue Spyre Therapeutics Inc Q1 2026 Earnings Missed Estimates as Clinical Pipeline Advances Kazatomprom Reports 17 Production Increase in Third Quarter Highlighting Operational Gains